Amrita Y Krishnan

5PUBLICATIONS
48CO-AUTHORS
BiomechanicsGene and molecular therapyMedical mycologyHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 21, 2026
mHealth-Supported Exercise Rehabilitation to Reverse Frailty After Autologous Transplantation in Multiple Myeloma: Randomized Controlled Trial.

|Aug 22, 2024
Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies.

Cyrille Touzeau, Amrita Y Krishnan, Philippe Moreau

|May 03, 2024
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival.

Marcelo C Pasquini, Paul K Wallace, Brent Logan

|Feb 23, 2024
A CD38-directed, single-chain T-cell engager targets leukemia stem cells through IFN-γ-induced CD38 expression.

Mariam Murtadha, Miso Park, Yinghui Zhu

|Jan 18, 2024
Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of Malignancies.

Mark M Stevens, Robert J Kimmerling, Selim Olcum

Pageof 1

Frequent Collaborators

1 joint publications

Mark M Stevens

1 joint publications

Noopur Raje

1 joint publications

Andrew Branagan

1 joint publications

Sundar Jagannath